E

ENCell Co Ltd
KOSDAQ:456070

Watchlist Manager
ENCell Co Ltd
KOSDAQ:456070
Watchlist
Price: 16 270 KRW -6.01%
Market Cap: 177.3B KRW

Operating Margin
ENCell Co Ltd

-324.1%
Current
-247%
Average
3.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-324.1%
=
Operating Profit
-18.9B
/
Revenue
5.8B

Operating Margin Across Competitors

No Stocks Found

ENCell Co Ltd
Glance View

ENCell Co Ltd is a KR-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-08-23. ENCell Co Ltd is a Korea-based company principally engaged in the development and research of new drugs. The firm is principally engaged in the development and research of cell and gene-based biopharmaceuticals. The firm is also engaged in the provision of biopharmaceutical quality testing services. In addition, the Company is engaged in the biopharmaceutical consignment production business.

Intrinsic Value
1 316.45 KRW
Overvaluation 92%
Intrinsic Value
Price
E
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-324.1%
=
Operating Profit
-18.9B
/
Revenue
5.8B
What is the Operating Margin of ENCell Co Ltd?

Based on ENCell Co Ltd's most recent financial statements, the company has Operating Margin of -324.1%.

Back to Top